13 matches for your search in the start-up spotlight
rss
11-Mar-2025
Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc. announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing ...
Including cell therapy candidates and related platform technologies
03-Dec-2024
Roche announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc., a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies. Based in San Diego, California, Poseida’s R&D portfolio includes pre-clinical and ...
"We are thrilled to welcome the highly reputable and talented Synple team into eMolecules"
26-Sep-2024
eMolecules, Inc. announced that it has acquired Synple Chem AG ("Synple"). Synple was founded in 2016 as a Spin-off from ETH Zürich. Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. WithSynple's virtual compound library, which ...
AstraZeneca has acquired all of Amolyt Pharma’s outstanding shares for up to $1.05 billion
18-Jul-2024
Andera Partners announced that its portfolio company Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, closed its previously announced acquisition by the global pharmaceutical company ...
Anacura adding multi-omics for drug discovery and diagnostics to its services
16-Jul-2024
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology. The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck ...
"Oxford Instruments’ leading reputation and international presence is a great springboard for our next stage of growth"
17-Jun-2024
Oxford Instruments plc announces that it has entered into an agreement to acquire FemtoTools AG, a developer of nanoindentation instruments. Completion is subject to certain closing conditions which are expected to be satisfied within the next four weeks. Based in Zurich, Switzerland, and founded ...
09-Jan-2024
Calypso Biotech BV, a leader in the development of Interleukin15 (IL-15) targeted therapies, announced that it has entered into an agreement to be acquired by Novartis AG. Calypso’s shareholders will receive an upfront payment of $250 million upon closing and are eligible to receive development ...
Acquisition initiates Bruker’s entry into functional single-cell biology research solutions
18-Aug-2023
Bruker Corporation and PhenomeX Inc. announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction. The proposed acquisition values PhenomeX at a total equity value of approximately $108 million. PhenomeX is a functional cell ...
Company secures regulatory approval in India and purchases state-of-the-art research, pilot production, and manufacturing facilities
06-Dec-2022
Perfect Day, Inc. today announces a deepening of its global vision and production prowess with two critical steps in India—a critical market for the company to scale its production capacity, extend its kinder, greener impact, and add top caliber talent to its team. The Food Safety and Standards ...
Companies commit to collaboration focused on product development and commercialization
18-Aug-2022
ADM (NYSE:ADM), a global leader in sustainable human and animal nutrition, and New Culture, a pioneering animal-free dairy company, have formed a strategic partnership to accelerate the development and commercialization of alternative dairy products. The partnership highlights both companies’ ...
